LENZ THERAPEUTICS INC. news, videos and press releases
For more news please use our advanced search feature.
LENZ THERAPEUTICS INC. - More news...
LENZ THERAPEUTICS INC. - More news...
- LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
- LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025
- LENZ Therapeutics to Host Commercial Day on April 15, 2025
- LENZ Therapeutics to Participate in Upcoming Investor Conferences
- LENZ Therapeutics to Participate in Upcoming Investor Conferences
- LENZ Therapeutics Reports Third Quarter 2024 Financial Results
- LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024
- CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100
- LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia
- LENZ Therapeutics Announces Presentations at Upcoming Ophthalmology and Optometry Medical Conferences
- LENZ Therapeutics to Participate in Upcoming Investor Conferences
- LENZ Therapeutics Reports Second Quarter 2024 Financial Results
- LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia
- LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024
- LENZ Therapeutics Announces $30 Million Investment from Ridgeback Capital
- LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024
- LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference
- LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
- LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024
